Log in

Relevant bibliographies by topics / Digene Hybrid Capture 2 technology / Journal articles

To see the other types of publications on this topic, follow the link: Digene Hybrid Capture 2 technology.

Journal articles on the topic 'Digene Hybrid Capture 2 technology'

Author: Grafiati

Published: 5 June 2025

Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Digene Hybrid Capture 2 technology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Hubbard, Roger A. "Human Papillomavirus Testing Methods." Archives of Pathology & Laboratory Medicine 127, no. 8 (2003): 940–45. http://dx.doi.org/10.5858/2003-127-940-hptm.

Full text

Abstract:

Abstract Testing for human papillomavirus (HPV) relies exclusively on techniques of molecular biology using nucleic acid probes. Tests for HPV using nucleic acid probes have been commercially available since the late 1980s, but early tests were cumbersome, involving the use of nucleic acid probes labeled with radioactive phosphorus (32P). These early HPV tests did not achieve widespread use because they did not detect all oncogenic HPV genotypes. The current commercial HPV detection kit, Digene's Hybrid Capture 2 kit, detects virtually all high-risk oncogenic HPV types, as well as most low-ris

APA, Harvard, Vancouver, ISO, and other styles

2

Siddiqui, Momin T., Kelly Hornaman, Cynthia Cohen, and Aziza Nassar. "ProEx C Immunocytochemistry and High-Risk Human Papillomavirus DNA Testing in Papanicolaou Tests With Atypical Squamous Cell (ASC-US) Cytology: Correlation Study With Histologic Biopsy." Archives of Pathology & Laboratory Medicine 132, no. 10 (2008): 1648–52. http://dx.doi.org/10.5858/2008-132-1648-pciahh.

Full text

Abstract:

Abstract Context.—Papanicolaou tests with atypical squamous cells of undetermined significance (ASC-US) cytology and adjunct testing for high-risk human papillomaviruses (hr-HPV) are helpful in detecting high-grade disease. Detection of disease may be further improved with molecular markers known to be overexpressed in cervical carcinoma. ProEx C detects 2 such molecular markers, minichromosome maintenance protein 2 and topoisomerase II, which are associated with abnormal cell cycle regulation. Objective.—To determine the utility of ProEx C as a marker for high-grade cervical intraepithelial n

APA, Harvard, Vancouver, ISO, and other styles

3

Irene, Adhiambo Okwaro, Onguru Daniel, Ogolla Sidney, and Odongo Esther. "Genotypes and Associated Risk Levels of Human Papilloma Virus among Female Patients Attending Rabuor Sub County Hospital, Kisumu." Mediterranean Journal of Basic and Applied Sciences (MJBAS) 7, no. 1 (2023): 01–13. https://doi.org/10.46382/MJBAS.2023.7101.

Full text

Abstract:

<strong>Background:</strong> Human papillomavirus is the main factor in the etiology of cervical cancer, with over 99.7% of cases being associated with high-risk human papillomavirus infection. Although the majority of HPV infections are asymptomatic and self-limiting, persistent HPV infection can result in genital warts, oropharyngeal cancer, and cervical cancer in women, in addition to various anogenital malignancies and other genital warts in both men and women. <strong>Method:</strong> This was a cross-sectional descriptive study which employed a convenience sampling technique where both q

APA, Harvard, Vancouver, ISO, and other styles

4

Okwaro, Irene Adhiambo, Daniel Onguru, Sidney Ogolla, and Esther Odongo. "Genotypes and Associated Risk Levels of Human Papilloma Virus among Female Patients Attending Rabuor Sub County Hospital, Kisumu." Mediterranean Journal of Basic and Applied Sciences 07, no. 01 (2023): 01–13. http://dx.doi.org/10.46382/mjbas.2023.7101.

Full text

Abstract:

Background: Human papillomavirus is the main factor in the etiology of cervical cancer, with over 99.7% of cases being associated with high-risk human papillomavirus infection. Although the majority of HPV infections are asymptomatic and self-limiting, persistent HPV infection can result in genital warts, oropharyngeal cancer, and cervical cancer in women, in addition to various anogenital malignancies and other genital warts in both men and women. Method: This was a cross-sectional descriptive study which employed a convenience sampling technique where both qualitative and quantitative method

APA, Harvard, Vancouver, ISO, and other styles

5

Bondar, O. V., A. I. Rybin, and V. V. Muzyka. "EXPERIENCE OF PRIMARY HPV TESTING IN CERVICAL CANCER SCREENING." Odes’kij medičnij žurnal (The Odessa Medical Journal), no. 1-2 (2023): 93–96. http://dx.doi.org/10.54229/2226-2008-2022-1-2-16.

Full text

Abstract:

REVIEWS EDITIONS SUBSCRIPTION EDITORIAL POLICY CONTACTS N 1–2 (179–180) 2022. P. 93–96 EXPERIENCE OF PRIMARY HPV TESTING IN CERVICAL CANCER SCREENING O. V. Bondar, A. I. Rybin, V. V. Muzyka Odesa National Medical University , Odesa, Ukraine The main cause of cervical cancer in almost 100% of cases is the human papillomavirus (HPV), which is also involved in the development of other cancers of the lower genital tract. The malignant transformation of the cervical epithelium is a continuous process that takes decades to develop, and early detection of HPV can prevent the long-term development of

APA, Harvard, Vancouver, ISO, and other styles

6

Ghofrani, Mohiedean, Chengquan Zhao, Diane D. Davey, et al. "Update on the College of American Pathologists Experience With High-Risk Human Papillomavirus Proficiency Testing for Cytology." Archives of Pathology & Laboratory Medicine 140, no. 12 (2016): 1371–74. http://dx.doi.org/10.5858/arpa.2015-0526-cp.

Full text

Abstract:

Context.— Since 2008, the College of American Pathologists has provided the human papillomavirus for cytology laboratories (CHPV) proficiency testing program to help laboratories meet the requirements of the Clinical Laboratory Improvement Amendments of 1988. Objectives.— To provide an update on trends in proficiency testing performance in the College of American Pathologists CHPV program during the 4-year period from 2011 through 2014 and to compare those trends with the preceding first 3 years of the program. Design.— Responses of laboratories participating in the CHPV program from 2011 thro

APA, Harvard, Vancouver, ISO, and other styles

7

Pas, Suzan D., Edwin Fries, Robert A. De Man, Albert D. M. E. Osterhaus, and Hubert G. M. Niesters. "Development of a Quantitative Real-Time Detection Assay for Hepatitis B Virus DNA and Comparison with Two Commercial Assays." Journal of Clinical Microbiology 38, no. 8 (2000): 2897–901. http://dx.doi.org/10.1128/jcm.38.8.2897-2901.2000.

Full text

Abstract:

A highly reproducible and sensitive real-time detection assay based on TaqMan technology was developed for the detection of hepatitis B virus (HBV) DNA and compared with two commercially available assays. The assay was validated with the Viral Quality Control panel, which also includes EUROHEP HBV DNA standards. This real-time PCR detection system had a dynamic range of 373 to 1010 genome copies per ml and showed an excellent correlation with both the commercial HBV Digene Hybrid Capture II microplate assay (Digene Diagnostics) and the HBV MONITOR assay (Roche Diagnostics). To demonstrate its

APA, Harvard, Vancouver, ISO, and other styles

8

Jastania, Raid, William R. Geddie, William Chapman, and Scott Boerner. "Characteristics of Apparently False-Negative Digene Hybrid Capture 2 High-Risk HPV DNA Testing." American Journal of Clinical Pathology 125, no. 2 (2006): 223–28. http://dx.doi.org/10.1309/qejbyt77ymtevj66.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Minniakhmetov, Ildar, Maksim Zabelin, Iliya Olkov, and Rita Khusainova. "Pilot project for screening cervical cancer using HPV testing." Problems in oncology 66, no. 6 (2020): 618–24. http://dx.doi.org/10.37469/0507-3758-2020-66-6-618-624.

Full text

Abstract:

The results of a large-scale pilot project on HPV-testing by the Hybrid Capture technology (digene HC2 HPV DNA Test) of 28928 women in the Republic of Bashkortostan were summarized. The frequency of high-risk HPV infection in the studied region of Russia was 10.6%, the average viral load was 319.97 RLU / COV ratio in the total sample, which corresponds to a high viral load (more than 3x107 genomic equivalents). In 5.4% of HPV-positive women, cervical pathology was revealed, cervical cancer in the early stages was detected in 21 (0.69%) women (20 cancer in situ and 1 cancer IA).

APA, Harvard, Vancouver, ISO, and other styles

10

Chan, Henry L. Y., Nancy W. Y. Leung, Tracy C. M. Lau, May L. Wong, and Joseph J. Y. Sung. "Comparison of Three Different Sensitive Assays for Hepatitis B Virus DNA in Monitoring of Responses to Antiviral Therapy." Journal of Clinical Microbiology 38, no. 9 (2000): 3205–8. http://dx.doi.org/10.1128/jcm.38.9.3205-3208.2000.

Full text

Abstract:

The aim of our study was to compare the performances of two new hepatitis B virus (HBV) DNA assays, a cross-linking assay (NAXCOR) and a hybrid-capture amplification assay (Digene), versus the widely used branched-DNA (bDNA) assay (Chiron) in the monitoring of HBV DNA levels during antiviral treatment. Serial serum samples from 12 chronically HBV infected patients undergoing a phase II trial of an antiviral drug, 2′,3′-dideoxy-5-fluoro-3′-thiacytidine (FTC), were studied. A total of 96 serum samples were tested for HBV DNA using the cross-linking, hybrid-capture amplification, and bDNA assays.

APA, Harvard, Vancouver, ISO, and other styles

11

Nam, K. H., J. S. Kim, S. H. Jung, et al. "Estimates of Agreement Between the Digene Hybrid Capture 2 and Oligonucleotide Microarray-based Human Papillomavirus Assay in Cervical Samples." Journal of Lower Genital Tract Disease 10, no. 3 (2006): 191. http://dx.doi.org/10.1097/00128360-200607000-00065.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Moore, Kathleen N., and Joan L. Walker. "High Risk Human Papillomavirus Testing: Guidelines for Use in Screening, Triage, and Follow-up for the Prevention and Early Detection of Cervical Cancer." Journal of the National Comprehensive Cancer Network 2, no. 6 (2004): 589–96. http://dx.doi.org/10.6004/jnccn.2004.0049.

Full text

Abstract:

The changes in cervical cytology characterization agreed on by the Bethesda committee meeting in 2001 created a category of atypical findings that has caused some management confusion. By description, the characterization of cervical cytology as only atypical implies a less worrisome prognosis. However, more than 40% of high-grade (CIN II or III or cancer) will be discovered within this category. The development and Food and Drug Administration approval of the Hybrid Capture 2 (HC-2; Digene Corporation, Gaithersburg, MD) for detecting high-risk human papillomavirus (HR-HPV) subtypes and the su

APA, Harvard, Vancouver, ISO, and other styles

13

Darwin, L. H., A. P. Cullen, P. M. Arthur, et al. "Comparison of Digene Hybrid Capture 2 and Conventional Culture for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Cervical Specimens." Journal of Clinical Microbiology 40, no. 2 (2002): 641–44. http://dx.doi.org/10.1128/jcm.40.02.641-644.2002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Khandker, Elisha. "Detection of human papillomavirus by hybrid capture and real time PCR methods in patients with chronic cervicitis and cervical intraepithelial neoplasia." IMC Journal of Medical Science 10, no. 2 (2017): 45–48. http://dx.doi.org/10.3329/imcjms.v10i2.31109.

Full text

Abstract:

Background and objectives: Cervical cancer due to Human papillomavirus (HPV) is one of the leading causes of morbidity and mortality in women. Testing of HPV can identify women who are at risk of cervical cancer. Nowadays, molecular methods like real time polymerase chain reaction (PCR) and hybrid capture technique are applied for detecting HPV in cervical specimens. The objective of the present study was to determine the rate of HPV infection in women with chronic cervicitis and cervical intraepithelial neoplasia (CIN) by a commercial real time polymerase chain reaction test kit and by a hybr

APA, Harvard, Vancouver, ISO, and other styles

15

Taku, Ongeziwe, Tracy L. Meiring, Inger Gustavsson, et al. "Acceptability of self- collection for human papillomavirus detection in the Eastern Cape, South Africa." PLOS ONE 15, no. 11 (2020): e0241781. http://dx.doi.org/10.1371/journal.pone.0241781.

Full text

Abstract:

Human papillomavirus (HPV) testing on vaginal self-collected and cervical clinician-collected specimens shows comparable performance. Self-sampling on FTA cards is suitable for women residing in rural settings or not attending regular screening and increases participation rate in the cervical cancer screening programme. We aimed to investigate and compare high-risk (HR)-HPV prevalence in clinician-collected and self-collected genital specimens as well as two different HPV tests on the clinician collected samples. A total of 737 women were recruited from two sites, a community health clinic (n

APA, Harvard, Vancouver, ISO, and other styles

16

Lau, George K. K., Yu-hung Leung, Daniel Y. T. Fong, et al. "High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation." Blood 99, no. 7 (2002): 2324–30. http://dx.doi.org/10.1182/blood.v99.7.2324.

Full text

Abstract:

The risk factors for hepatitis due to hepatitis B virus (HBV) reactivation in patients positive for hepatitis B surface antigen (HBsAg) treated with autologous hematopoietic cell transplantation (HCT) are unknown. We evaluated 137 consecutive patients (23 positive for HBsAg, 37 positive for hepatitis B surface antibody, and 77 negative for HBV) who underwent HCT. Serial serum ALT were measured before transplant and after transplant at 1 to 4 weekly intervals for the first year and then at 2 to 12 weekly intervals thereafter. Before HCT, basic core promoter (T1762/A1764) and precore (A1896) HBV

APA, Harvard, Vancouver, ISO, and other styles

17

Sasagawa, Toshiyuki, Toshiyuki Maehama, Yasuhiro Osaka, et al. "Comparison of the digene hybrid capture 2 and Roche cobas 4800 HPV tests for detection of CIN2+ in a referral population in Japan." Journal of Medical Virology 90, no. 5 (2018): 972–80. http://dx.doi.org/10.1002/jmv.25025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Ho, Stephen K. N., Fu-Keung Li, Kar-Neng Lai, and Tak-Mao Chan. "Comparison of the CMV Brite Turbo Assay and the Digene Hybrid Capture CMV DNA (Version 2.0) Assay for Quantitation of Cytomegalovirus in Renal Transplant Recipients." Journal of Clinical Microbiology 38, no. 10 (2000): 3743–45. http://dx.doi.org/10.1128/jcm.38.10.3743-3745.2000.

Full text

Abstract:

We compared the CMV Brite Turbo Kit (BT) and the Digene Hybrid Capture CMV DNA (version 2.0) assay (HC2) in the quantitation of pp65 antigenemia and cytomegalovirus (CMV) DNA levels in immunosuppressed renal transplant recipients. Of 123 blood specimens collected from 24 renal transplant recipients, BT and HC2 assays detected 35 and 39 positive samples, respectively. The overall concordance rate between the two assays was 90%. Discordant results were observed at low levels of viremia, so that 8 samples were HC2 positive but BT negative and another 4 were BT positive but HC2 negative. There was

APA, Harvard, Vancouver, ISO, and other styles

19

Ginocchio, C. C., D. Barth, and F. Zhang. "Comparison of the Third Wave Invader Human Papillomavirus (HPV) Assay and the Digene HPV Hybrid Capture 2 Assay for Detection of High-Risk HPV DNA." Journal of Clinical Microbiology 46, no. 5 (2008): 1641–46. http://dx.doi.org/10.1128/jcm.01824-07.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Liu, Stephanie S., Karen K. L. Chan, Tina N. Wei, et al. "Clinical performance of the Roche Cobas 4800 HPV test for primary cervical cancer screening in a Chinese population." PLOS ONE 17, no. 8 (2022): e0272721. http://dx.doi.org/10.1371/journal.pone.0272721.

Full text

Abstract:

High-risk human papillomavirus (HR-HPV) testing has become an increasing important strategy in primary cervical cancer screening in recent years. It warrants the evaluation of molecular-based HPV tests for accuracy and efficacy of screening. The performance of Roche Cobas 4800 HPV test was validated and compared with Digene Hybrid Capture 2 (HC2) high-risk HPV DNA test for primary screening in a large Chinese screening cohort. Of 6345 women screened, overall agreement between Cobas and HC2 was 92.23% (95% CI: 91.57–92.89). The inter-assay agreement was correlated with the severity of underlyin

APA, Harvard, Vancouver, ISO, and other styles

21

Bumbuliene, Zana, Jonas Alisauskas, and Agne Sepetiene. "High-risk hpv infection in sexually active and non active young women." Open Medicine 6, no. 4 (2011): 456–62. http://dx.doi.org/10.2478/s11536-011-0042-0.

Full text

Abstract:

AbstractTo determine the prevalence of high-risk HPV infection before first vaginal intercourse and after initiation of sexual activity in 14-22 years old girls, to find which HPV types occur most commonly. During the gynecologic exam cervical swabs were collected. Specimens were tested using Hybrid Capture 2 DNA test. In positive samples digene HPV genotyping test was performed. Subjects included 264 women, of whom 169 (64.0%) reported previous sexual activity and 95 (36.0%) had not yet had vaginal intercourse. There were 43 cases (16.3%) of high risk HPV, with 39 cases in those reporting sex

APA, Harvard, Vancouver, ISO, and other styles

22

Bae, J. H., C. J. Kim, T. C. Park, S. E. Namkoong, and J. S. Park. "Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure." International Journal of Gynecologic Cancer 17, no. 6 (2007): 1271–77. http://dx.doi.org/10.1111/j.1525-1438.2007.00945.x.

Full text

Abstract:

We aimed to investigate whether postconization human papillomavirus (HPV) DNA testing can predict treatment failure and improve the accuracy of conventional follow-up in women with high-grade cervical intraepithelial neoplasia (CIN). Between March 2001 and October 2005, 120 patients with confirmed CIN 2 or 3 were treated with loop electrosurgical excision procedure (LEEP) and were enrolled. Six patients were lost to the follow-up. Postconization follow-up was performed at every 3–6 months during the first year and then annually. Specimens were tested for the presence of HPV, using the Hybrid C

APA, Harvard, Vancouver, ISO, and other styles

23

Bibbo, Marluce, Zi-Xuan Wang, Krister Jones, Charalambos Solomides, Rossitza Draganova-Tacheva, and Robert Stapp. "Review of Cytology Practice at Thomas Jefferson University Hospital before and after High-Risk Human Papillomavirus Testing." Acta Cytologica 60, no. 6 (2016): 534–39. http://dx.doi.org/10.1159/000446271.

Full text

Abstract:

Objective: We performed a retrospective review of Papanicolaou (Pap) testing to assess whether the cytology practice in our institution was affected by the introduction of high-risk (HR) human papillomavirus (HPV) assays over time. Study Design: Cytology, HPV and histopathology records were retrieved from our laboratory information system from 2003 to 2015. Records for Digene Hybrid Capture 2®, Hologic Cervista® and Roche Cobas® HPV assays were obtained. A 3-month follow-up for HPV detected cases was performed, and results were correlated with cytology and biopsies. A 1-year follow-up of HPV 1

APA, Harvard, Vancouver, ISO, and other styles

24

Levi, Angelique W., Jane I. Bernstein, Pei Hui, Kara Duch, Kevin Schofield, and David C. Chhieng. "A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes." Archives of Pathology & Laboratory Medicine 140, no. 2 (2016): 153–57. http://dx.doi.org/10.5858/arpa.2015-0027-oa.

Full text

Abstract:

Context All Food and Drug Administration–approved methods in the United States for human papillomavirus testing including the Hybrid Capture 2 human papillomavirus assay and the Roche cobas human papillomavirus test are approved for cytology specimens collected into ThinPrep media but not for specimens collected into SurePath solution. Objective To compare the performance of the Roche cobas and Hybrid Capture 2 tests for the detection of high-risk human papillomavirus using both ThinPrep and SurePath preparations as part of a validation study. Design One thousand three hundred seventy-one liqu

APA, Harvard, Vancouver, ISO, and other styles

25

Tachy, E. Diego, C. S. José Andrade, and B. Sérgio Neves. "Post-Combustion CO₂ Capture from Exhaust Gas by Amines and Membranes." Applied Mechanics and Materials 830 (March 2016): 19–29. http://dx.doi.org/10.4028/www.scientific.net/amm.830.19.

Full text

Abstract:

There is a necessity to reduce GHG emission because climate change may have critical consequences in many places around the world. The main gas which causes climate change is CO2 which is released into atmosphere mainly by industries and vehicles. This research aims to compare two technologies for CO2 capture: chemical absorption with membranes, and to present hybrid processes using both of these. A review of the state of art for CO2 capture is used in this research. The capture by absorption with amines is the state of the art for post-combustion because it produces CO2 with higher purity and

APA, Harvard, Vancouver, ISO, and other styles

26

Gish, R. G., N. W. Y. Leung, T. L. Wright, et al. "Dose Range Study of Pharmacokinetics, Safety, and Preliminary Antiviral Activity of Emtricitabine in Adults with Hepatitis B Virus Infection." Antimicrobial Agents and Chemotherapy 46, no. 6 (2002): 1734–40. http://dx.doi.org/10.1128/aac.46.6.1734-1740.2002.

Full text

Abstract:

ABSTRACT A multicenter, open-label study was performed to evaluate the safety, anti-hepatitis B virus (anti-HBV) activity, and pharmacokinetics of emtricitabine therapy administered once daily for 8 weeks to patients infected with HBV. Clinical and virologic evaluations were completed at the baseline; at 7, 14, 28, 42, and 56 days during treatment; and at 24, 48, and 28 days posttreatment. Forty-nine patients were enrolled in five dose cohorts (doses of 25, 50, 100, 200, and 300 mg, all of which were administered once daily [q.d.]). Peak plasma emtricitabine concentrations occurred within 1.5

APA, Harvard, Vancouver, ISO, and other styles

27

Tabrizi, S. N., M. P. Stevens, Z. A. Khan, C. Chow, M. A. Devitt, and S. M. Garland. "Comparison of PapType to Digene Hybrid Capture 2, Roche Linear Array, and Amplicor for Detection of High-Risk Human Papillomavirus Genotypes in Women with Previous Abnormal Pap Smears." Journal of Clinical Microbiology 50, no. 8 (2012): 2796–98. http://dx.doi.org/10.1128/jcm.01064-12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Bae, Jae-Man, Kyung Tae Min, Ji Young Shin, et al. "Comparison of Digene Hybrid Capture 2, GeneMatrix PapilloScreen, and a PCR sequencing assay in detecting high-risk and probable high-risk oncogenic HPV genotypes in specimens from Korean women." Archives of Virology 159, no. 8 (2014): 1909–16. http://dx.doi.org/10.1007/s00705-014-2020-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

González-Zamora, Eduardo, and Ilich A. Ibarra. "CO2 capture under humid conditions in metal–organic frameworks." Materials Chemistry Frontiers 1, no. 8 (2017): 1471–84. http://dx.doi.org/10.1039/c6qm00301j.

Full text

Abstract:

An emerging technology for CO<sub>2</sub> capture is the construction of hybrid adsorbent MOFs via confinement of water inside the pores. This review article describes the recent progress in this field.

APA, Harvard, Vancouver, ISO, and other styles

30

Anuar, Siti A., Wan N. R. Wan Isahak, and Mohd S. Masdar. "Carbon nanoflake hybrid for biohydrogen CO 2 capture: Breakthrough adsorption test." International Journal of Energy Research 44, no. 4 (2020): 3148–59. http://dx.doi.org/10.1002/er.5169.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Hong, Jin Hwa, Mi Kyung Kim, In Ho Lee, et al. "Association Between Serum Cytokine Profiles and Clearance or Persistence of High-Risk Human Papillomavirus Infection: A Prospective Study." International Journal of Gynecologic Cancer 20, no. 6 (2010): 1011–16. http://dx.doi.org/10.1111/igc.0b013e3181e513e5.

Full text

Abstract:

Introduction:The cytokines that may be associated with the clearance or persistence of high-risk human papillomavirus (HPV) infection in patients with mild dysplasia or less of the uterine cervix were determined.Methods:A prospective study of 160 patients who harbored high-risk HPV with histologically confirmed mild dysplasia or less between January 2006 and August 2008 was performed. All patients were followed up at every 4 months during the first year. Human papillomavirus DNA tests by the Hybrid Capture 2 method (Digene, Gaithersburg, Md) were performed at every visit on all patients. Blood

APA, Harvard, Vancouver, ISO, and other styles

32

Jung, Sunkyung, Byungdoo Lee, Kap No Lee, Yonggoo Kim, and Eun-Jee Oh. "Clinical Validation of Anyplex II HPV HR Detection Test for Cervical Cancer Screening in Korea." Archives of Pathology & Laboratory Medicine 140, no. 3 (2016): 276–80. http://dx.doi.org/10.5858/arpa.2015-0117-oa.

Full text

Abstract:

Context The Anyplex II HPV HR detection kit (Seegene Inc, Seoul, Korea) is a new, multiplex, real-time polymerase chain reaction assay to detect individual 14 high-risk (HR) human papillomavirus (HPV) types in a single tube. Objective To evaluate the clinical performance of the HPV HR kit in predicting high-grade squamous intraepithelial lesions and cervical intraepithelial lesions grade 2 or worse in cervical cancer screening. Design We analyzed 1137 cervical samples in Huro Path medium (CelltraZone, Seoul, Korea) from Korean women. The clinical performance of the HPV HR kit was compared with

APA, Harvard, Vancouver, ISO, and other styles

33

Moriarty, Ann T., Mary R. Schwartz, Galen Eversole, et al. "Human Papillomavirus Testing and Reporting Rates: Practices of Participants in the College of American Pathologists Interlaboratory Comparison Program in Gynecologic Cytology in 2006." Archives of Pathology & Laboratory Medicine 132, no. 8 (2008): 1290–94. http://dx.doi.org/10.5858/2008-132-1290-hptarr.

Full text

Abstract:

Abstract Context.—Oncogenic, high-risk human papillomavirus (HR-HPV) testing is used to evaluate women who are older than 20 years with atypical squamous cells of undetermined significance (ASC-US) and in conjunction with a screening Papanicolaou test in women older than 30 years. Objectives.—To evaluate the 2006 laboratory practice data from laboratories incorporating human papillomavirus (HPV) testing with the Papanicolaou test. Design.—To use the College of American Pathologists (CAP) Supplemental Questionnaire Survey for 2006 to determine laboratory practices of participants in the CAP Int

APA, Harvard, Vancouver, ISO, and other styles

34

Ahn, W., J. Shin, D. Park, et al. "Comparison of three different methods for the detection of human papillomavirus infected in cervical lesions." Journal of Clinical Oncology 27, no. 15_suppl (2009): e22166-e22166. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e22166.

Full text

Abstract:

e22166 Background: Several techniques are in use for HPV DNA detection: Hybrid Capture IIR(HCIIR) assay, PCR-based DNA microarray and Luminex-based assay. This study was aimed to examine the performances of three validated HPV assays. We compared the concordance between the three methods for detecting HPV in cervical specimen. Methods: Cervical samples of 189 Korean women (21∼77 ages, average 41.2 age) were tested for HPV detection in this study. We examined the performances of three validated HPV assays according to each method's instructions : 1) Hybrid Capture IIR (HCIIR) assay (HCIIR; Dige

APA, Harvard, Vancouver, ISO, and other styles

35

GONZÁLEZ, C., J. CANALS, M. ORTIZ, et al. "Prevalence and determinants of high-risk human papillomavirus (HPV) infection and cervical cytological abnormalities in imprisoned women." Epidemiology and Infection 136, no. 2 (2007): 215–21. http://dx.doi.org/10.1017/s0950268807008382.

Full text

Abstract:

SUMMARYThe aim of the study was to estimate the prevalence and risk factors associated with infection by high-risk human papillomavirus (HR-HPV) in cervix and squamous intra-epithelial lesions (SIL) in imprisoned women. This was done by a cross-sectional study of imprisoned women attending the gynaecological clinic in Foncalent prison in Alicante, Spain. The study period was from May 2003 to December 2005. HR-HPV infection was determined through Digene HPV Test, Hybrid Capture II (HC-II). HPV typing was determined by multiplex nested PCR assay combining degenerate E6/E7 consensus primers. Mult

APA, Harvard, Vancouver, ISO, and other styles

36

Denninghoff, Valeria, Felicitas von Petery, Cristóbal Fresno, et al. "Clinical implementation of a cervical cancer screening program via co-testing at a university hospital." PLOS ONE 17, no. 12 (2022): e0278476. http://dx.doi.org/10.1371/journal.pone.0278476.

Full text

Abstract:

The Human Papillomavirus (HPV) test is a crucial technology for cervical cancer prevention because it enables programs to identify women with high-risk HPV infection who are at risk of developing cervical cancer. Current U.S. Preventive Services Task Force recommendations include cervical cancer screening every three years with cervical cytology alone or every five years with either high-risk HPV testing alone or high-risk HPV testing combined with cytology (co-testing). In Argentina, 7,548 new cervical cancer cases are diagnosed each year with 3,932 deaths attributed to this cause. Our study

APA, Harvard, Vancouver, ISO, and other styles

37

Tabrizi, S. N., S. Phillips, and S. M. Garland. "P5.073 Comparison of Cobas® 4800 HPV Assay to Digene Hybrid Capture 2, Roche Linear Array, and Amplicor in the Detection of High-Risk Human Papillomavirus Genotypes in Women with Previous Abnormal Pap Smears." Sexually Transmitted Infections 89, Suppl 1 (2013): A357.2—A357. http://dx.doi.org/10.1136/sextrans-2013-051184.1117.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Stevens, M. P., S. M. Garland, E. Rudland, J. Tan, M. A. Quinn, and S. N. Tabrizi. "Comparison of the Digene Hybrid Capture 2 Assay and Roche AMPLICOR and LINEAR ARRAY Human Papillomavirus (HPV) Tests in Detecting High-Risk HPV Genotypes in Specimens from Women with Previous Abnormal Pap Smear Results." Journal of Clinical Microbiology 45, no. 7 (2007): 2130–37. http://dx.doi.org/10.1128/jcm.02438-06.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Phillips, Samuel, Suzanne M. Garland, Jeffery H. Tan, Michael A. Quinn, and Sepehr N. Tabrizi. "Comparison of the Roche Cobas® 4800 HPV assay to Digene Hybrid Capture 2, Roche Linear Array and Roche Amplicor for Detection of High-Risk Human Papillomavirus Genotypes in Women undergoing treatment for cervical dysplasia." Journal of Clinical Virology 62 (January 2015): 63–65. http://dx.doi.org/10.1016/j.jcv.2014.11.017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Matthews-Greer, Janice, Gloria Caldito, Guillermo A. Herrera, and Elba A. Turbat-Herrera. "Hybrid Capture-2 is Better Than In Situ Hybridization: A Study Comparison With Cervical Biopsies." Applied Immunohistochemistry & Molecular Morphology 18, no. 2 (2010): 192–94. http://dx.doi.org/10.1097/pai.0b013e3181bb5022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Gandra, Sumanth, Aline Azar, Nisha Kini, Bruce Barton, and Mireya Wessolossky. "11. Prevalence of anal high risk human papilloma virus (hr-HPV) infection and cytological." Sexual Health 10, no. 6 (2013): 575. http://dx.doi.org/10.1071/shv10n6ab11.

Full text

Abstract:

Background Although anal HPV infection and cytological abnormalities are highly prevalent among HIV-infected MSM patients, there is limited data on HIV-infected heterosexual men and women. Since November 2010 at our clinic, anal cancer screening with both hr-HPV and cytology was routinely performed in all HIV-infected patients. The purpose of the study was to evaluate the prevalence of anal hr-HPV infection and cytological abnormalities among our cohort of HIV-infected MSM, heterosexual men and women. We also evaluated the performance of hr-HPV and abnormal cytology in detecting high-grade dys

APA, Harvard, Vancouver, ISO, and other styles

42

Quader, M. Abdul, and Shamsuddin Ahmed. "A Hybrid Fuzzy MCDM Approach to Identify Critical Factors and CO2 Capture Technology for Sustainable Iron and Steel Manufacturing." Arabian Journal for Science and Engineering 41, no. 11 (2016): 4411–30. http://dx.doi.org/10.1007/s13369-016-2134-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Zhang, Yue, Brice Freeman, Pingjiao Hao, and Gary T. Rochelle. "Absorber modeling for NGCC carbon capture with aqueous piperazine." Faraday Discussions 192 (2016): 459–77. http://dx.doi.org/10.1039/c6fd00030d.

Full text

Abstract:

A hybrid system combining amine scrubbing with membrane technology for carbon capture from natural gas combined cycle (NGCC) power plants is proposed in this paper. In this process, the CO<sub>2</sub> in the flue gas can be enriched from 4% to 18% by the membrane, and the amine scrubbing system will have lower capture costs. Aqueous piperazine (PZ) is chosen as the solvent. Different direct contact cooler (DCC) options, multiple absorber operating conditions, optimal intercooling designs, and different cooling options have been evaluated across a wide range of inlet CO<sub>2</sub>. Amine scrub

APA, Harvard, Vancouver, ISO, and other styles

44

Pau, J. S., William K. S. Pao, Suet Peng Yong, and Paras Qadir Memon. "Evaluation of Relative Permeability Models in CO₂/Brine System Using Mixed and Hybrid Finite Element Method." Applied Mechanics and Materials 819 (January 2016): 401–5. http://dx.doi.org/10.4028/www.scientific.net/amm.819.401.

Full text

Abstract:

The requirement to reduce 40% carbon emission in 2020 has lead Malaysia to adopt the carbon capture and storage (CCS) technology in 2009. In this research, the pressure and transport differential equation for CO2 – brine phases flow is discretized using mixed and hybrid finite element method (MHFEM) which ensures the local continuity of the finite elements. Result shows that CO2 flow radially outward from the injection well. Three relative permeability models are investigated and it was find out that the simplified relative permeability model (SRM) has reduced the computational time by 8.3 tim

APA, Harvard, Vancouver, ISO, and other styles

45

Hooper, Jody E., Jessica F. Hebert, Amy Schilling, et al. "Hybrid Capture 2 is as Effective as PCR Testing for High-risk Human Papillomavirus in Head and Neck Cancers." Applied Immunohistochemistry & Molecular Morphology 23, no. 4 (2015): 266–72. http://dx.doi.org/10.1097/pdm.0000000000000036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Song, Changpo, Fengyong Sun, and Fan Yang. "Research on Power Conversion and Control Technology of Ocean Buoy Tidal Energy Power Supply System." Journal of Marine Science and Engineering 13, no. 6 (2025): 1129. https://doi.org/10.3390/jmse13061129.

Full text

Abstract:

This paper proposes a Boost + LLC converter-based power controller for ocean buoy tidal energy systems. To optimize output power across a wide input voltage range (40–120 V) and achieve effective power tracking control, we introduce two key innovations as follows: (1) a variable-mode inverter hybrid control strategy, combining smooth-mode switching with inverter control to enable wide gain range regulation. (2) An improved Grey Wolf Optimization (GWO) algorithm, enhanced by integrating a PSO-based elite wolf search strategy preventing local optima and maximizing power capture. Saber and Matlab

APA, Harvard, Vancouver, ISO, and other styles

47

Acquaviva, Giorgia, Michela Visani, Viviana Sanza, et al. "Different Methods in HPV Genotyping of Anogenital and Oropharyngeal Lesions: Comparison between VisionArray® Technology, Next Generation Sequencing, and Hybrid Capture Assay." Journal of Molecular Pathology 2, no. 1 (2021): 29–41. http://dx.doi.org/10.3390/jmp2010004.

Full text

Abstract:

(1) Background: Human papillomaviruses (HPVs) are known to be related to the development of about 5% of all human cancers. The clinical relevance of HPV infection has been deeply investigated in carcinomas of the oropharyngeal area, uterine cervix, and anogenital area. To date, several different methods have been used for detecting HPV infection. The aim of the present study was to compare three different methods for the diagnosis of the presence of the HPV genome. (2) Methods: A total of 50 samples were analyzed. Twenty-five of them were tested using both next generation sequencing (NGS) and

APA, Harvard, Vancouver, ISO, and other styles

48

Lörincz, Attila T., and Ralph M. Richart. "Human Papillomavirus DNA Testing as an Adjunct to Cytology in Cervical Screening Programs." Archives of Pathology & Laboratory Medicine 127, no. 8 (2003): 959–68. http://dx.doi.org/10.5858/2003-127-959-hpdtaa.

Full text

Abstract:

Abstract Our objective was to review current large studies of human papillomavirus (HPV) DNA testing as an adjunct to the Papanicolaou test for cervical cancer screening programs. We analyzed 10 large screening studies that used the Hybrid Capture 2 test and 3 studies that used the polymerase chain reaction test in a manner that enabled reliable estimates of accuracy for detecting or predicting high-grade cervical intraepithelial neoplasia (CIN). Most studies allowed comparison of HPV DNA and Papanicolaou testing and estimates of the performance of Papanicolaou and HPV DNA as combined tests. T

APA, Harvard, Vancouver, ISO, and other styles

49

Sammartano, G., G. Patrucco, M. Avena, C. Bonfanti, and A. Spanò. "ENHANCING TERRESTRIAL POINT CLOUDS USING UPSAMPLING STRATEGY: FIRST OBSERVATION AND TEST ON FARO FLASH TECHNOLOGY." International Archives of the Photogrammetry, Remote Sensing and Spatial Information Sciences XLVIII-2/W4-2024 (February 14, 2024): 381–88. http://dx.doi.org/10.5194/isprs-archives-xlviii-2-w4-2024-381-2024.

Full text

Abstract:

Abstract. Nowadays 3D digitization through the combination or hybridization of different sensors, with the final aim of accelerating the phases of data acquisition and storage, develops user friendly and robotics systems, making efficient the operator role. New technologies as Hybrid Reality Capture™ (HRC), with Flash Technology (FARO Tech.) certainly fits into this market trend, and it is characterized by rapid acquisition, involving 3D scanning data with panoramic images contribution. The system is still under patent, and nothing is yet released on the technology. This research presents the

APA, Harvard, Vancouver, ISO, and other styles

50

Goutam, Kumar Paul, and Das Rajesh. "Fundamentals of Nano-scale Materials and Multifunctional Properties : Review towards Biomedical Applications." International Journal of HIT Transaction on ECCN Vol. 8, Jun 2022 (2022): 26–30. https://doi.org/10.5281/zenodo.7307708.

Full text

Abstract:

<em>Department of Physics, Hoogly Mohsin College, Hoogly -712101, West Bengal, India</em> <em>School of Applied Sciences and Humanities, Haldia Institute of Technology (Autonomy), Haldia -721657, West Bengal, India</em> Rare Earth Doped ZnO based nano-structured proper-shaped, defect-free bio-compatible Semiconducting Quantum Dots with high photoluminescence and quantum efficiency have great impact in modern Biomedical applications. Doped ZnO nano-structure with proper wt% of Li, Na, N, P, Ne, or Bi shows red luminescence with high intensity. Y<sub>2</sub>O<sub>3</sub>: Eu, SrTiO<sub>3</sub>:

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!